نتایج جستجو برای: lipid lowering medications

تعداد نتایج: 232460  

Journal: :European heart journal 2003
Jennifer H Walsh Gerald Yong Craig Cheetham Gerald F Watts Gerard J O'Driscoll Roger R Taylor Daniel J Green

AIMS Despite the importance of both lipid metabolism and physical activity to cardiovascular health, few studies have examined the effect of exercise training on vascular function in hypercholesterolaemic humans. METHODS AND RESULTS A randomized, cross-over design investigated the effect of 8 weeks of combined aerobic and resistance exercise training on conduit and resistance vessel function ...

Journal: :JAMA 2009
Elena V Kuklina Paula W Yoon Nora L Keenan

CONTEXT Studies show that a large proportion of adults with high levels of low-density lipoprotein cholesterol (LDL-C) remain untreated or undertreated despite growing use of lipid-lowering medications. OBJECTIVE To investigate trends in screening prevalence, use of cholesterol-lowering medications, and LDL-C levels across 4 study cycles (1999-2000, 2001-2002, 2003-2004, and 2005-2006). DES...

2013
Matthew J Sorrentino

and Introduction Abstract LDL cholesterol is the primary target of therapy to lower cardiovascular risk. Statins are medications of first choice to lower LDL cholesterol, but cannot be tolerated in up to 10% of individuals. Intermittent dosing strategies for statins can help reduce muscle symptoms in some patients. A Mediterranean-type diet supplemented with plant stanols and sterols, fiber and...

2016
Jonathan D. Schofield Yifen Liu Prasanna Rao-Balakrishna Rayaz A. Malik Handrean Soran

Diabetes mellitus is associated with a considerably increased risk of premature atherosclerotic cardiovascular disease. Intensive glycemic control has essentially failed to significantly improve cardiovascular outcomes in clinical trials. Dyslipidemia is common in diabetes and there is strong evidence that cholesterol lowering improves cardiovascular outcomes, even in patients with apparently u...

2017
Majid Afshar Donghong Wu Ramon Durazo-Arvizu Frank G Aguilar Ravi Kalhan Sonia M Davis Robert Kaplan Oana L Klein Eliana P Mende Maria S Pattany Martha L Daviglus

RATIONALE Substantial variation in the prevalences of obstructive lung disease exist between Hispanic/Latino heritage groups. Experimental studies have posited biological mechanisms linking serum lipids and lipid-lowering medications with obstructive lung disease. The aim of this study is to examine the associations of serum lipid levels with the prevalences of asthma and chronic obstructive pu...

2012
Rachel H. Mackey

Methods In a multiethnic study of 5,598 men and women ages 45 to 84 years old, without baseline CHD, excluding subjects on lipid-lowering medications, triglycerides 400 mg/dl, or missing values, we evaluated associations of HDL-C and nuclear magnetic resonance spectroscopy-measured HDL-P with cIMT and incident CHD (myocardial infarction, CHD death, and angina, n 227 events; mean 6.0 years follo...

2015
Chris Schilling Duncan Mortimer Kim Dalziel Emma Heeley John Chalmers Philip Clarke

Background and objective Many guidelines for clinical decisions are hierarchical and non-linear. Evaluating if these guidelines are used in practice requires methods that can identify such structures and thresholds. We use classification and regression trees (CART) to analyse prescribing patterns of Australian General Practitioners (GPs) for the primary prevention of cardiovascular disease. Our...

Journal: :The New Zealand medical journal 2005
Natasha Rafter Jennie Connor Jason Hall Rod Jackson Isobel Martin Varsha Parag Stephen Vander Hoorn Anthony Rodgers

AIM To measure the use of three major types of cardiovascular medications (antiplatelet, blood pressure lowering, and cholesterol lowering) in primary care, and their level of targeting to individuals at high absolute risk of a cardiovascular event. METHODS Demographic, risk factor, and prescribing data from the Dunedin Royal New Zealand College of General Practitioners Research Unit database...

Journal: :iranian journal of pharmaceutical research 0
maryam kouchak a nanotechnology research center, ahvaz jundishapur university of medical sciences, ahvaz, iran b department of pharmaceutics, school of pharmacy, ahvaz jundishapur university of medical sciences, ahvaz, iran reza bahmandar nanotechnology research center, ahvaz jundishapur university of medical sciences, ahvaz, iran neda bavarsad a nanotechnology research center, ahvaz jundishapur university of medical sciences, ahvaz, iran b department of pharmaceutics, school of pharmacy, ahvaz jundishapur university of medical sciences, ahvaz, iran fereydoun farrahi department of ophthalmology, imam khomeini hospital, ahvaz jundishapur university of medical sciences, ahvaz, iran

dorzolamide ophthalmic drop is one of the most common glaucoma medications but it has a short residence time in the eye. the aim of this study is to develop ocular dorzolamide hcl nanoliposomes (drz – nanoliposomes) and to evaluate their potential use for the treatment of ocular hypertension. nanoliposomes were prepared using reverse-phase evaporation vesicle (rev) and thin layer hydration (tlh...

Journal: :Archives of internal medicine 2005
Richard E Scranton Melissa Young Elizabeth Lawler Daniel Solomon David Gagnon J Michael Gaziano

BACKGROUND Whether statins reduce the risk of fractures is still contested. Several studies support a favorable association, whereas post hoc analyses of statin-randomized trials have failed to find a benefit. We sought to assess this possible relationship in a large population of elderly, predominantly male veterans. METHODS We established the study population using all health care encounter...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید